Midterm outcomes of fenestrated TEVAR using physician-modified endovascular grafts for zone 2.

Vascular
Jiaxue BiZongwei Liu

Abstract

To summarize the experience and midterm outcomes of physician-modified endovascular grafts for zone 2 thoracic endovascular aortic repair. A retrospective analysis was conducted of 51 consecutive patients (mean age 57.6 ± 12.5 years, 39 males) treated with thoracic endovascular aortic repair using physician-modified endovascular grafts for reconstructing the left subclavian artery from November 2015 to December 2019. The primary endpoints during follow-up were the overall mortality, aorta-related mortality, and major complications. The secondary endpoints were reintervention and the patency of the target branches, the demographics and technical details were also described and analyzed. Sixty-three thoracic stent-grafts were deployed in 51 patients and emergency surgery was performed in 10 patients (19.6%). Technical success was 94.1% (48/51). The incidence of perioperative complications was 15.7%, and the 30-day mortality was 0%. At a mean follow-up of 42.0 ± 14.4 months (range, 14-63 months), all the left subclavian arteries remained patent. All-cause mortality was 3.9% (2/51) and not aorta-related deaths. Estimated survival at one and three years was 98.0 ± 1.9% and 96.0 ± 2.8%, respectively. The physician-modified endovascul...Continue Reading

References

Nov 3, 2009·Journal of Vascular Surgery·Jon S MatsumuraUNKNOWN Society for Vascular Surgery
Jan 11, 2011·Journal of Vascular Surgery·Philipp GeisbüschDittmar Böckler
Jul 25, 2013·Journal of Vascular Surgery·Carsten M BüngerChristoph A Nienaber
Oct 30, 2015·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·George JosephRaj Sahajanandan
Nov 22, 2015·The Annals of Thoracic Surgery·Stephen D WaterfordAli Khoynezhad
May 18, 2016·Journal of Vascular Surgery·Sean A CrawfordMatthew G Doyle
Jan 14, 2017·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery· Writing CommitteeJ Schmidli
Apr 8, 2017·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Tun WangChen-Zi Yang
Jun 10, 2017·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Ludovic CanaudKiyofumi Morishita
Sep 8, 2017·General Thoracic and Cardiovascular Surgery·Xun YuanChristoph A Nienaber
Dec 5, 2017·The Annals of Thoracic Surgery·Chun-Yang HuangChun-Che Shih
Dec 16, 2017·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·Jiechang ZhuFanguo Hu
Mar 30, 2019·Journal of Vascular Surgery·Ludovic CanaudThomas Gandet
May 11, 2019·Annals of Vascular Surgery·Shuhei MiuraAkira Yamada
Jun 27, 2019·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Ludovic CanaudThomas Gandet
Oct 28, 2019·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Lucien Chassin-TrubertLudovic Canaud

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.